Sight Sciences, Inc. (SGHT)
8.89
+0.42
(+4.96%)
USD |
NASDAQ |
Oct 09, 16:00
8.89
0.00 (0.00%)
After-Hours: 20:00
Sight Sciences Cash from Operations (Quarterly) : -5.663M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.663M |
| March 31, 2026 | -7.029M |
| December 31, 2025 | -1.827M |
| September 30, 2025 | -8.719M |
| June 30, 2025 | -7.543M |
| March 31, 2025 | -11.60M |
| December 31, 2024 | -3.221M |
| September 30, 2024 | 0.362M |
| June 30, 2024 | -9.706M |
| March 31, 2024 | -9.786M |
| December 31, 2023 | -6.484M |
| September 30, 2023 | -9.828M |
| June 30, 2023 | -13.49M |
| Date | Value |
|---|---|
| March 31, 2023 | -17.38M |
| December 31, 2022 | -15.50M |
| September 30, 2022 | -20.19M |
| June 30, 2022 | -18.30M |
| March 31, 2022 | -21.97M |
| December 31, 2021 | -10.72M |
| September 30, 2021 | -16.51M |
| June 30, 2021 | -12.44M |
| March 31, 2021 | -12.87M |
| December 31, 2020 | -8.55M |
| September 30, 2020 | -8.615M |
| June 30, 2020 | -5.448M |
| March 31, 2020 | -9.561M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Integra LifeSciences Holdings Corp. | 22.80M |
| Abbott Laboratories | 2.488B |
| AngioDynamics, Inc. | -15.33M |
| Alphatec Holdings, Inc. | 20.51M |
| AtriCure, Inc. | 22.19M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.019M |
| Cash from Financing (Quarterly) | 0.474M |
| Free Cash Flow | -23.33M |
| Free Cash Flow Per Share (Quarterly) | -0.1042 |
| Free Cash Flow to Equity (Quarterly) | -6.765M |
| Free Cash Flow to Firm (Quarterly) | -4.384M |
| Free Cash Flow Yield | -4.91% |